More about
Atherosclerotic Cardiovascular Disease
Clinical Guidance
Lipid Management
Cardiovascular Disease Prevention
2018 ACC/AHA Multi-Society Cholesterol Guideline Overview
Clinical Guidance
Lipid Management
Cardiovascular Disease Prevention
Epidemiology of Cholesterol and Cardiovascular Disease
Clinical Guidance
Lipid Management
Lipid and Lipoprotein Basics
Secondary Hyperlipidemia
Clinical Guidance
Lipid Management
Lipid and Lipoprotein Basics
Familial Hyperlipidemias
Clinical Guidance
Lipid Management
Lipid and Lipoprotein Basics
Laboratory Measurement
Clinical Guidance
Lipid Management
Lipid and Lipoprotein Basics
Lipid and Lipoprotein Basics
Clinical Guidance
Lipid Management
Lipid and Lipoprotein Basics
Clinical Lipid Management
News
July 22, 2024
2 min read
Save
Top in cardiology: Implications of new ASCVD risk calculator; benefits of salt reduction
The American Heart Association’s PREVENT equations predicted that people with stage 1 hypertension have a lower 10-year risk for atherosclerotic CVD compared with the Pooled Cohort Equations.
News
July 15, 2024
3 min read
Save
New risk calculator may reduce number of patients suggested for BP-lowering medication
Ten-year atherosclerotic CVD risk for people with stage 1 hypertension was substantially lower when estimated with the new PREVENT equations vs. the Pooled Cohort Equations, researchers reported.
News
July 10, 2024
2 min read
Save
Benefits of aspirin for secondary prevention in ASCVD seemingly equal in men vs. women
Patient sex had seemingly no effect on the safety and efficacy of aspirin for patients with atherosclerotic CVD, according to secondary analysis of the ADAPTABLE trial published in JAMA Cardiology.